Results 21 to 30 of about 125,156 (180)

Medullary Thyroid Cancer: An Introduction [PDF]

open access: yesCurrent Oncology, 2019
Medullary thyroid cancer (mtc) is a rare cancer, making up perhaps only a few percent of all thyroid cancers […]
openaire   +2 more sources

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
Recommendations for clinical and molecular identification of LS, surgical and endoscopic management of LS‐associated colorectal cancer and preventive measures for cancer were produced. The emphasis was on surgical and gastroenterological aspects of the cancer spectrum.
T. T. Seppälä   +18 more
wiley   +1 more source

Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19

open access: yesСибирский онкологический журнал, 2022
Background. Coronavirus disease 2019 (COVID-19) is a pandemic of the new millennium. COVID-19 can cause both pulmonary and systemic infammation, and can rapidly progress to multiple organ failure. Data on the relationship between COVID-19 and the thyroid
E. V. Ryabchenko
doaj   +1 more source

Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek   +18 more
wiley   +1 more source

Cabozantinib in Progressive Medullary Thyroid Cancer [PDF]

open access: yesJournal of Clinical Oncology, 2013
Purpose Cabozantinib, a tyrosine kinase inhibitor (TKI) of hepatocyte growth factor receptor (MET), vascular endothelial growth factor receptor 2, and rearranged during transfection (RET), demonstrated clinical activity in patients with medullary thyroid cancer (MTC) in phase I.
ELISEI, ROSSELLA   +18 more
openaire   +6 more sources

Papillary Thyroid Carcinoma with Primary Hyperparathyroidism: A Report of Two Cases and a Brief Literature Review

open access: yesEndocrinology Research and Practice, 2013
Coexistence of medullary thyroid carcinoma and primary hyperparathyroidism (PHPT) is well described, however, the association of non-medullary thyroid cancer and PHPT is less recognized.
Mehmet Aşık   +5 more
doaj   +1 more source

Genetic susceptibility to hereditary non-medullary thyroid cancer

open access: yesHereditary Cancer in Clinical Practice, 2022
Non-medullary thyroid cancer (NMTC) is the most common type of thyroid cancer. With the increasing incidence of NMTC in recent years, the familial form of the disease has also become more common than previously reported, accounting for 5–15% of NMTC ...
Tina Kamani   +3 more
doaj   +1 more source

Genetics of medullary thyroid cancer: An overview

open access: yesInternational Journal of Surgery, 2017
Medullary thyroid carcinoma (MTC) represents 3-5% of thyroid cancers. 75% is sporadic and 25% is the dominant component of the hereditary multiple endocrine neoplasia (MEN) type 2 syndromes. Three different subtypes of MEN2, such as MEN2A, MEN2B, and Familial MTC (FMTC) have been defined, based on presence or absence of hyperparathyroidism ...
Accardo, Giacomo   +11 more
openaire   +2 more sources

Extrusion‐Based Bioprinting of Living Bioinks for Tissue and Organ Engineering

open access: yesAdvanced Materials Technologies, EarlyView.
Extrusion‐based bioprinting is presented as the most versatile route for fabricating living, heterogeneous tissues. Its ability to combine diverse bioinks, support matrices, and advanced printhead geometries transforms familiar constraints into powerful biofabrication opportunities.
Eric Silberman   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy